Fate Therapeutics Inc (NASDAQ:FATE)
| 33.82 Delayed Data As of Aug 12 |  +1.17 / +3.58%Today’s Change | 17.10 Today|||52-Week Range 92.70 | -42.20% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Wolchko J Scott President & Chief Executive Officer |  Sale | 10/22/2021 | 30,000 | $58.88 | $1.8M | -42.68% |
Wolchko J Scott President & Chief Executive Officer | Sale | 8/19/2021 | 20,000 | $88.01 | $1.8M | -60.50% |
Tahl Cindy R Secretary & General Counsel | Sale | 1/03/2022 | 27,812 | $59.86 | $1.7M | -43.90% |
Tahl Cindy R Secretary & General Counsel | Sale | 10/01/2021 | 21,844 | $58.96 | $1.3M | -43.16% |
Dulac Edward John Iii Chief Financial Officer | Sale | 9/28/2021 | 19,460 | $62.53 | $1.2M | -44.37% |
Wolchko J Scott President & Chief Executive Officer | Sale | 1/20/2022 | 30,000 | $40.21 | $1.2M | -11.70% |
Wolchko J Scott President & Chief Executive Officer | Sale | 11/18/2021 | 20,000 | $54.27 | $1.1M | -38.51% |
Valamehr Bahram Chief Development Officer | Sale | 9/13/2021 | 15,809 | $65.94 | $1.0M | -48.59% |
Tahl Cindy R Secretary & General Counsel | Sale | 1/03/2022 | 16,900 | $58.84 | $994.4K | -43.90% |
Wolchko J Scott President & Chief Executive Officer | Sale | 1/10/2022 | 20,894 | $47.17 | $985.6K | -31.41% |
Page of 13